Ebglyss (lebrikizumab-lbkz) - Eli Lilly
Wynzora (calcipotriene/betamethasone dipropionate) - MC2 Therap, Almirall
Ilumya (tildrakizumab-asmn) - Sun Pharma, Almirall
Klisyri (tirbanibulin ointment) - Hanmi, Almirall, Athenex, PharmaEssentia
https://www.businesswire.com/news/home/20241110301062/en/Almirall%E2%80%99s-Nine-Month-2024-Results-Almirall-Reports-Strong-Performance-at-Q3-2024---Driven-by-Successful-Commercial-Execution-of-the-Dermatology-Portfolio-Fuelled-by-Biologics-Growth
 
Nov 11, 2024
 
Prev Next